CREDIT SUISSE AG/ - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 145 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,145,994
-35.1%
44,853
-27.1%
0.00%
-50.0%
Q2 2023$1,765,140
+71.4%
61,546
+43.2%
0.00%
+100.0%
Q1 2023$1,030,111
+61.9%
42,975
+14.5%
0.00%0.0%
Q4 2022$636,407
+29.9%
37,524
+13.4%
0.00%0.0%
Q3 2022$490,000
+25.6%
33,087
+33.5%
0.00%
Q2 2022$390,000
-43.6%
24,778
-3.4%
0.00%
-100.0%
Q1 2022$692,000
-28.1%
25,641
-1.4%
0.00%0.0%
Q4 2021$963,000
-18.0%
26,004
+5.8%
0.00%0.0%
Q3 2021$1,174,000
+195.0%
24,571
+108.5%
0.00%
Q2 2021$398,000
-34.4%
11,783
-19.9%
0.00%
Q1 2021$607,000
-71.7%
14,702
-70.3%
0.00%
-100.0%
Q4 2020$2,148,000
-33.7%
49,531
-34.4%
0.00%
-50.0%
Q3 2020$3,240,000
+328.0%
75,561
+366.0%
0.00%
+100.0%
Q2 2020$757,000
+187.8%
16,215
-16.2%
0.00%
Q1 2020$263,000
-59.0%
19,359
-67.2%
0.00%
Q4 2019$641,00059,0030.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2023
NameSharesValueWeighting ↓
SEVEN EIGHT CAPITAL, LP 46,819$2,031,0000.47%
Orbimed Advisors 1,206,886$49,844,0000.47%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 25,000$1,033,0000.40%
ARK Investment Management 3,331,889$137,607,0000.27%
FEDERATED HERMES, INC. 3,203,000$132,284,0000.26%
MGO ONE SEVEN LLC 26,990$1,114,0000.19%
Koss-Olinger Consulting, LLC 20,000$826,0000.14%
Jump Financial, LLC 35,400$1,462,0000.14%
Graham Capital Management, L.P. 74,262$3,067,0000.14%
New England Research & Management, Inc. 6,005$248,0000.14%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders